62 studies found for:
Open Studies | "Mesothelioma"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma
|
||||
| 2 | Recruiting |
Tivantinib in Treating Patients With Previously Treated Metastatic or Recurrent Malignant Mesothelioma
|
||||
| 3 | Recruiting |
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
|
||||
| 4 | Recruiting |
Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
|
||||
| 5 | Recruiting |
Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
|
||||
| 6 | Recruiting |
Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma
|
||||
| 7 | Recruiting |
SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma
|
||||
| 8 | Recruiting |
PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma
|
||||
| 9 | Recruiting |
Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)
|
||||
| 10 | Recruiting |
Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos
|
||||
| 11 | Recruiting |
Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers
|
||||
| 12 | Recruiting |
Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
|
||||
| 13 | Not yet recruiting |
Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment
|
||||
| 14 | Unknown † |
Axitinib in Malignant Mesothelioma
|
||||
| 15 | Recruiting |
A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma
|
||||
| 16 | Recruiting |
Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma
|
||||
| 17 | Recruiting |
CRS-207 Cancer Vaccine in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma
|
||||
| 18 | Recruiting |
Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite
|
||||
| 19 | Recruiting |
The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma
|
||||
| 20 | Not yet recruiting |
Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma
|
† Indicates status has not been verified in more than two years
